Search Results

There are 6803 results for: content related to: Bevacizumab: not as good with more adverse reactions? Response

  1. You have free access to this content
    Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  2. You have free access to this content
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  3. You have free access to this content
    Anti-vascular endothelial growth factor for diabetic macular oedema

    Intervention Review

    The Cochrane Library

    Gianni Virgili, Mariacristina Parravano, Francesca Menchini and Jennifer R Evans

    Published Online : 24 OCT 2014, DOI: 10.1002/14651858.CD007419.pub4

  4. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 247–255, Jignesh J. Patel, Margaret A.S. Mendes, Mark Bounthavong, Melissa L.D. Christopher, Daniel Boggie and Anthony P. Morreale

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2753.2010.01546.x

  5. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  6. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 892–903, He Wen, Jinsong Hao and S. Kevin Li

    Version of Record online : 4 DEC 2012, DOI: 10.1002/jps.23387

  7. You have free access to this content
    The ABCs of RVO: A review of retinal venous occlusion

    Clinical and Experimental Optometry

    Volume 97, Issue 4, July 2014, Pages: 311–323, Derek MacDonald

    Version of Record online : 20 NOV 2013, DOI: 10.1111/cxo.12120

  8. Aflibercept for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Salman Sarwar, Elizabeth Clearfield, Mohamed Kamel Soliman, Mohammad Ali Sadiq, Andrew J Baldwin, Mostafa Hanout, Aniruddha Agarwal, Yasir J Sepah, Diana V Do and Quan Dong Nguyen

    Published Online : 8 FEB 2016, DOI: 10.1002/14651858.CD011346.pub2

  9. You have free access to this content
    Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion

    Intervention Review

    The Cochrane Library

    Tasanee Braithwaite, Afshan A Nanji, Kristina Lindsley and Paul B Greenberg

    Published Online : 1 MAY 2014, DOI: 10.1002/14651858.CD007325.pub3

  10. You have free access to this content
    Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration

    Acta Ophthalmologica

    Volume 92, Issue 8, December 2014, Pages: 713–723, Geoffrey K. Broadhead, Thomas Hong and Andrew A. Chang

    Version of Record online : 12 JUN 2014, DOI: 10.1111/aos.12463

  11. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion

    Intervention Review

    The Cochrane Library

    Danny Mitry, Catey Bunce and David Charteris

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD009510.pub2

  12. You have free access to this content
    Response to Replacing ranibizumab with bevacizumab on the Pharmaceutical Benefits Scheme: where does the current evidence leave us?

    Clinical and Experimental Optometry

    Volume 95, Issue 5, September 2012, Pages: 541–543, John G O'Shea

    Version of Record online : 5 JUN 2012, DOI: 10.1111/j.1444-0938.2012.00736.x

  13. Age-Related Macular Degeneration

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 8, August 2013, Pages: 838–855, Lily K. Cheung and Angie Eaton

    Version of Record online : 11 APR 2013, DOI: 10.1002/phar.1264

  14. You have free access to this content
    Anti-vascular endothelial growth factor for myopic choroidal neovascularization

    Clinical & Experimental Ophthalmology

    Volume 40, Issue 1, January/February 2012, Pages: e98–e110, Danny S Ng, Alvin KH Kwok and Clement W Chan

    Version of Record online : 5 FEB 2012, DOI: 10.1111/j.1442-9071.2011.02684.x

  15. You have free access to this content
    Treatment of diabetic retinopathy with anti-VEGF drugs

    Acta Ophthalmologica

    Volume 89, Issue 3, May 2011, Pages: 203–207, Michael Waisbourd, Michaella Goldstein and Anat Loewenstein

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1755-3768.2010.02010.x

  16. You have free access to this content
    Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

    Intervention Review

    The Cochrane Library

    Maria José Martinez-Zapata, Arturo J Martí-Carvajal, Ivan Solà, José I Pijoán, José A Buil-Calvo, Josep A Cordero and Jennifer R Evans

    Published Online : 24 NOV 2014, DOI: 10.1002/14651858.CD008721.pub2

  17. You have free access to this content
    Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation

    Acta Ophthalmologica

    Volume 90, Issue 5, August 2012, Pages: e389–e398, Ching-Long Chen, Chang-Min Liang, Yi-Hao Chen, Ming-Cheng Tai, Da-Wen Lu and Jiann-Torng Chen

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1755-3768.2012.02426.x

  18. Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study

    Journal of Cellular Biochemistry

    Volume 108, Issue 6, 15 December 2009, Pages: 1410–1417, Raquel Costa, Ângela Carneiro, Ana Rocha, Ana Pirraco, Manuel Falcão, Luísa Vasques and Raquel Soares

    Version of Record online : 26 OCT 2009, DOI: 10.1002/jcb.22378

  19. You have free access to this content
    Ranibizumab for age-related macular degeneration: a meta-analysis of dose effects and comparison with no anti-VEGF treatment and bevacizumab

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 3, June 2014, Pages: 234–239, S. Jiang, C. Park and J. C. Barner

    Version of Record online : 17 MAR 2014, DOI: 10.1111/jcpt.12146

  20. You have free access to this content
    Differential effects of bevacizumab, ranibizumab and aflibercept on cell viability, phagocytosis and mitochondrial bioenergetics of retinal pigment epithelial cell

    Acta Ophthalmologica

    Volume 93, Issue 8, December 2015, Pages: e631–e643, Shwu-Jiuan Sheu, Yung-Mei Chao, Ni-Chun Liu and Julie Y.H. Chan

    Version of Record online : 14 MAY 2015, DOI: 10.1111/aos.12745